These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7900514)

  • 41. Oral misoprostol for induction of labour.
    Syed S; Chaudhri R; Rizvi F; Afzal M
    J Coll Physicians Surg Pak; 2010 Feb; 20(2):102-5. PubMed ID: 20378037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of labour after fetal death: a randomized controlled trial of two prostaglandin regimens.
    Kanhai HH; Keirse MJ
    Br J Obstet Gynaecol; 1989 Dec; 96(12):1400-4. PubMed ID: 2695155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Termination of early pregnancy with RU 486 (mifepristone) in combination with a prostaglandin analogue (sulprostone).
    Swahn ML; Bygdeman M
    Acta Obstet Gynecol Scand; 1989; 68(4):293-300. PubMed ID: 2694744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dose-dependent effect of locally administered sulprostone gel on serum luteal and placental hormones in cervix priming in the 1st trimester].
    Rath W; Pitzel L; Hilgers R; Kuhn W
    Zentralbl Gynakol; 1989; 111(10):634-44. PubMed ID: 2750356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Randomized study of sulprostone versus misoprostol in the cervical preparation before elective abortion in nulliparous women].
    Schaub B; Fuhrer P; Sainte-Rose D
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(5):505-10. PubMed ID: 7499737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of a new synthetic prostaglandin (sulprostone) in the interruption of pregnancy after the first 90 days].
    Segre A; Maccarone G; Goles A; Masignà-Ricciardi P; Borsari S
    Minerva Ginecol; 1983 Oct; 35(10):681-7. PubMed ID: 6664605
    [No Abstract]   [Full Text] [Related]  

  • 47. [Rupture of a healthy uterus in a prostaglandin-induced abortion in the second trimester].
    Larue L; Marpeau L; Percque M; Castiel J; Guettier X; Maghioracos P; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):269-72. PubMed ID: 2071873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Labor induction with prostaglandins in severe fetal developmental abnormalities].
    Haidbauer R; Staudach A; Lassmann R; Batka M; Steiner H; Riedl B
    Gynakol Rundsch; 1990; 30 Suppl 1():193-5. PubMed ID: 2079266
    [No Abstract]   [Full Text] [Related]  

  • 49. [Critical pulmonary edema following cesarean section].
    Puura A; Schavikin L; Yli-Kesti O; Ylä-Outinen A; Virtanen V; Kaukinen S
    Duodecim; 1995; 111(3):249-52. PubMed ID: 8654288
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinico-experimental evaluation on the use of sulprostone, new PGE2 derivative. I. Interruption of pregnancy in the first trimester].
    Stoppelli I; Piras G; Dessole S
    Minerva Ginecol; 1983 Dec; 35(12):819-23. PubMed ID: 6243062
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinico-experimental evaluation on the use of sulprostone, new PGE2 derivative. II. Interruption of pregnancy in the second trimester].
    Stoppelli I; Piras G; Dessole S
    Minerva Ginecol; 1983 Dec; 35(12):825-8. PubMed ID: 6672683
    [No Abstract]   [Full Text] [Related]  

  • 52. The morphological characteristics and ultrastructural aspects of cervical ripening induced by sulprostone.
    Di Lieto A; Catalano D; Campanile M; Negri R; Albano G; Dell'Isola A; Paladini A; Orlandi GR
    Acta Eur Fertil; 1988; 19(1):33-6. PubMed ID: 3414330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of intravenous oxytocin to vaginal misoprostol for mid trimester labor induction.
    Hidar S; Jerbi M; Khaïri H
    Am J Obstet Gynecol; 2006 Jul; 195(1):332-3; author reply 333-4. PubMed ID: 16813766
    [No Abstract]   [Full Text] [Related]  

  • 54. The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone.
    Martinez de Tejada B; Martillotti G; Lapaire O; Hoesli I; Irion O
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):988-93. PubMed ID: 19941444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conservative management of ectopic pregnancy: prospective randomized clinical trial of methotrexate versus prostaglandin sulprostone by combined transvaginal and systemic administration.
    Fernandez H; Baton C; Lelaidier C; Frydman R
    Fertil Steril; 1991 Apr; 55(4):746-50. PubMed ID: 2009998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cervix priming in induced abortion in the 1st trimester using intracervical administration of sulprostone gel].
    Rath W; Meyer D; Harder D; Hilgers R; Kuhn W
    Geburtshilfe Frauenheilkd; 1985 Jan; 45(1):51-6. PubMed ID: 3845028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Termination of early human pregnancy with RU 486 (mifepristone) and the prostaglandin analogue sulprostone: a multi-centre, randomized comparison between two treatment regimens.
    Bahzad C; Wyssling H; Saraya L; Shi YE; Prasad RN; Swahn ML; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Aug; 4(6):718-25. PubMed ID: 2778058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Abortion induction in disordered pregnancy in the 1st and 2d trimester by local and systemic administration of sulprostone].
    Tabarelli M; Heim K; Mayr P; Karpellus E
    Gynakol Rundsch; 1988; 28 Suppl 2():221-4. PubMed ID: 3234920
    [No Abstract]   [Full Text] [Related]  

  • 59. Menstrual regulation by intramuscular injections of 16-phenoxy-tetranor PGE2 methyl sulfonylamide (sulprostone). A multicentre study. World Health Organization.
    Br J Obstet Gynaecol; 1989 Feb; 96(2):207-12. PubMed ID: 2539185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complete recovery after 2 h of cardiopulmonary resuscitation following high-dose prostaglandin treatment for atonic uterine haemorrhage.
    Krumnikl JJ; Böttiger BW; Strittmatter HJ; Motsch J
    Acta Anaesthesiol Scand; 2002 Oct; 46(9):1168-70. PubMed ID: 12366517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.